Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

Core Viewpoint - The proposed sale of Exact Sciences Corporation to Abbott Laboratories is under investigation to assess whether the offered price of $105.00 per share adequately reflects the company's value [1]. Group 1: Transaction Details - Exact Sciences shareholders will receive $105.00 in cash for each share they own as part of the proposed transaction [1]. - The law firm Kahn Swick & Foti, LLC is investigating the adequacy of this consideration and the process leading to the proposed sale [1]. Group 2: Legal Rights and Contact Information - Shareholders who believe the transaction undervalues the company can contact Kahn Swick & Foti to discuss their legal rights without any obligation or cost [2]. - Contact details for KSF Managing Partner Lewis S. Kahn are provided for shareholders to reach out regarding the investigation [2].